Stoneridge Investment Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,545
| Closed | -$693K | – | 118 |
|
|
2024
Q4 | $693K | Buy |
10,545
+6,355
| +152% | +$418K | 0.25% | 78 |
|
|
2024
Q3 | $295K | Buy |
+4,190
| New | +$295K | 0.11% | 85 |
|
|
2023
Q1 | – | Sell |
-4,341
| Closed | -$449K | – | 101 |
|
|
2022
Q4 | $449K | Buy |
4,341
+1,399
| +48% | +$145K | 0.25% | 71 |
|
|
2022
Q3 | $249K | Sell |
2,942
-6,388
| -68% | -$541K | 0.15% | 88 |
|
|
2022
Q2 | $773K | Hold |
9,330
| – | – | 0.43% | 60 |
|
|
2022
Q1 | $719K | Buy |
+9,330
| New | +$719K | 0.34% | 72 |
|
|
2021
Q4 | – | Sell |
-4,241
| Closed | -$328K | – | 113 |
|
|
2021
Q3 | $328K | Buy |
4,241
+1,475
| +53% | +$114K | 0.16% | 95 |
|
|
2021
Q2 | $231K | Sell |
2,766
-3,100
| -53% | -$259K | 0.11% | 96 |
|
|
2021
Q1 | $443K | Buy |
+5,866
| New | +$443K | 0.23% | 83 |
|
|
2020
Q4 | – | Sell |
-2,861
| Closed | -$218K | – | 109 |
|
|
2020
Q3 | $218K | Buy |
+2,861
| New | +$218K | 0.14% | 100 |
|